5WK0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aligos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 4.475 EUR 1.59% Market Closed

Market Cap: €27.5m

	Aligos Therapeutics Inc F:5WK0	US
C	CITIC Securities Co Ltd OTC:CIIHY	CN
	Gold79 Mines Ltd OTC:WPGCF	CA
	CoStar Group Inc NASDAQ:CSGP	US
	MFE-MEDIAFOREUROPE NV F:T0J1	IT
	Mahaka Radio Integra Tbk PT IDX:MARI	ID
	Jardine Matheson Holdings Ltd OTC:JMHLY	HK
	Societe de Services de Participations, de Direction et d'Elaboration SA F:YX5	BE
	Steel Partners Holdings LP OTC:SPLP	US
C	China Resources Cement Holdings Ltd OTC:CJRCF	HK
	Medipal Holdings Corp OTC:MEPDF	JP

Profitability Summary

Aligos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-4 025%

Negative 3Y Average Operating Margin

-1 764%

Declining Operating Margin

-586% > -4 025%

Negative Net Margin

-1 107%

Negative 3Y Average Net Margin

-1 469%

Declining Net Margin

-593% > -1 107%

Negative Free Cash Flow Margin

-3 794%

Negative 3Y Average Free Cash Flow Margin

-1 642%

Declining Free Cash Flow Margin

-582% > -3 794%

Negative ROE

-197%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-782%

Declining ROIC

-425% > -1 031%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.